Biologic Outsourcing STREAM

  1. Introducing The MAST® Autosampling Solution 12/6/2024

    The MAST® Autosampling Solution automates aseptic sample transfers, maintaining sterility while integrating with analytical technologies to provide reliable insights into critical process parameters.

  2. AGC Biologics Capacity Update October 2025: Large Molecule 10/16/2025

    Michael Brotz provides an in-depth look at our Seattle site and the unique capabilities of the facility, including its single-use and stainless-steel capacity, new manufacturing lines, and more.

  3. Meet The Experts: PAT, Raman Spectroscopy, And Chemometrics 4/14/2023

    Gain a better understanding of process analytical technology (PAT), Raman spectroscopy, chemometrics, and Raman applications in bioprocessing.

  4. GMP-Focused Platform Processes For Microbial, pDNA, And mRNA 3/25/2025

    Mario Kraft, Director of Process Development at AGC Biologics' Heidelberg facility, explains how platform processes optimize microbial, plasmid DNA, and mRNA production.

  5. Targeting The Fast Lane With Optimized Viral Detection 4/6/2023

    Discover a groundbreaking method that allows you to accelerate viral detection by combining the broad range of NGS with the sensitivity of PCR.

  6. Handle Your Drug Product With The Highest Quality And Safety 9/19/2023

    Explore our fill line capabilities, including vial and syringe handling. Schedule an immersive tour of our drug product filling facility in Denmark. Our experienced team is available to discuss your needs.

  7. Building A Strong Safety Culture In The Biopharmaceutical Industry 1/25/2025

    Explore how fostering a strong safety culture — rooted in accountability, collaboration, and proactive risk management — can drive operational excellence and long-term success in biopharmaceuticals.

  8. Abzena Capacity Update October 2025: Large Molecule 10/16/2025

    Accelerate your therapeutic antibody and complex protein development with advanced mammalian cell line platforms that move from DNA to RCB in just 10 weeks.

  9. New Approaches To Tailored Release Profiles 7/7/2025

    Tailored drug release is evolving from formulation tactic to precision therapy strategy, optimizing timing, site, and rate of delivery for improved patient outcomes.

  10. New Protein A Device Set To Redefine Biomanufacturing 3/25/2025

    Discover how the Gore Protein A Membrane Device, in collaboration with AGC Biologics, can revolutionize your manufacturing processes, enhancing efficiency, scalability, and innovation from discovery to GMP-level production.